Loading company details...
Beta
Latest Form 4 (Sep 22, 2026): John Leite (Global Chief Commercial Off): Sale of 4,015 shares, $160.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | John Leite, Global Chief Commercial Off | Sale | 4,015 | $160.6K |
| Sep 16, 2026 | Jens Holstein | Sale | 5,000 | $204.7K |
| Sep 4, 2026 | Jonathan Wygant, VP, Chief Accounting Officer | Tax Withholding | 1,361 | $61.1K |
| Sep 4, 2026 | John Leite, Global Chief Commercial Off | Tax Withholding | 3,961 | $177.8K |
| Sep 4, 2026 | Phillip G. Febbo, Chief Scientific & Med Officer | Tax Withholding | 3,639 | $163.3K |
| Sep 4, 2026 | Rebecca Chambers, Chief Financial Officer | Tax Withholding | 3,603 | $161.7K |
| Sep 4, 2026 | Annie McGuire, EVP, General Counsel | Tax Withholding | 3,215 | $144.3K |
| Sep 4, 2026 | Marc Stapley, Chief Executive Officer | Tax Withholding | 8,782 | $394.1K |
| Sep 3, 2026 | Muna Bhanji | Sale | 1,864 | $80.1K |
| Jun 22, 2026 | Karin Eastham | Sale | 3,200 | $168.9K |